United States · FDA National Drug Code directory

FEIRZA 1.5/30 TM

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70700-309_f8fd9b04-56e7-6537-c324-1b3579e73f80
Product NDC: 70700-309
Form: KIT
Composition / generic term: Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 1.5 mg/30 mcg and Ferrous Fumarate Tablets, 75 mg
Labeler: Xiromed LLC
Marketing category: ANDA
Marketing start / end (source format): 20250129
Source listing expiry: 20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

3 POUCH in 1 CARTON (70700-309-85) / 1 BLISTER PACK in 1 POUCH (70700-309-84) / 1 KIT in 1 BLISTER PACK · 70700-309-85

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →